Skip to main content

Hormone Replacement Therapy and Hypertension: Relationship to the Renin-Angiotensin System

  • Conference paper
Hypertension in Postmenopausal Women

Abstract

Senaca observed early in the first century A.D., “the illustrious founder of the guild and profession of medicine [Hippocrates] remarked that women never lost their hair or suffered from pain in the feet; and yet nowadays they run short of hair and are afflicted with gout … in rivalling male indulgences, they have also rivalled the ills to which men are heirs“.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Centers for Disease Control and Prevention (1993) Annual summary of births, marriages, divorces, and deaths: United States, 1992. Monthly vital statistics report from the Centers for Disease Control and Prevention, vol 14, pp 1–24

    Google Scholar 

  2. Sealey JE, Cholst I, Glorioso N, Troffa C, Weintraub ID, James GD, Laragh JH (1987) Sequential changes in plasma luteinizing hormone and plasma prorenin during the menstrual cycle. J Clin Endocrinol Metab 65: 1–5

    Article  PubMed  CAS  Google Scholar 

  3. Horowitz MC (1993) Cytokines and estrogen in bone: anti-osteoporotic effects. Science 260: 626

    Article  PubMed  CAS  Google Scholar 

  4. Colditz GA, Willet WC, Stampfer MJ, Rosher B, Speizer FF, Hennekens CH (1987) Menopause and the risk of coronary heart disease in women. N Engl J Med 316: 1105–1110

    Article  PubMed  CAS  Google Scholar 

  5. Barrett-Connor E, Bush TL (1991) Estrogen and coronary heart disease in women. JAMA 265: 1861–1867

    Article  PubMed  CAS  Google Scholar 

  6. Keaney JF, Shwaery GT, Xu A, Nicolosi RJ, Foxall TL, Vita JA (1993) Preserva¬tion of endothelial function in hypercholesterolemia through the antioxidant properties of estrogens. Circulation 88: 1–79

    Google Scholar 

  7. Meilahn EN, Kuller LH, Matthews KAA, Kiss JE (1992) Hemostatic factors according to menopausal status and use of hormone replacement therapy. Ann Epidemiol 2: 445–455

    Article  PubMed  CAS  Google Scholar 

  8. Magness RR, Rosenfeld CR (1989) Local and systemic estradiol- 17beta: effects on uterine and systemic vasodilation. Am J Physiol XX: E536–E542

    Google Scholar 

  9. Rosano GMC, Sarrel PM, Poole-Wilson PA, Collins P (1993) Beneficial effect of estrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet 342: 133–136

    Article  PubMed  CAS  Google Scholar 

  10. Ravnikar VA (1993) Hormone replacement therapy in the primary prevention of cardiovascular disease: benefits, risks, and compliance issues. In: Wenger NK, Speroff L, Packard B (eds) Cardiovascular health and disease in women. Le Jacq Communications, Greenwich, pp 181–187

    Google Scholar 

  11. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR (1992) Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117: 1016–1037

    PubMed  CAS  Google Scholar 

  12. Laragh JH, Sealey JE, Ledingham JGG, Newton MA (1967) Oral contracept-ives: renin, aldosterone and high blood pressure. JAMA 201: 918–922

    Article  PubMed  CAS  Google Scholar 

  13. Baird DT, Glasier AF (1993) Hormonal contraception. N Engl J Med 328: 1543–1549

    Article  PubMed  CAS  Google Scholar 

  14. Russel RP, Sullivan MA (1970) The pill and hypertension. Johns Hopkins Med J 127: 287–293

    Google Scholar 

  15. Woods JW (1988) Oral contraceptives and hypertension. Hyertension 11 [Suppl II]: II. 11–II. 15

    Google Scholar 

  16. McCaffrey TA (1985) Preliminary dissertation. Purdue University, Indiana

    Google Scholar 

  17. Van Beresteyn ECH, van’t Hoff MA, de Waard H (1989) Contributions of ovarian failure and aging to blood pressure in normotensive perimenopausal women: a mixed longitudinal study. Am J Epidemiol 129: 947–955

    PubMed  Google Scholar 

  18. Luotola H (1983) Blood pressure and hemodynamics in postmenopausal women during estradiol 17-beta substitution. Ann Clin Res 15 [Suppl 38]: 1–121

    PubMed  Google Scholar 

  19. Laragh JH (1972) Oral contraceptive hypertension. Postgrad Med 52: 98–105

    PubMed  CAS  Google Scholar 

  20. Steingold KA, Matt DW, DeZiegler D, Sealey JE, Fratkin M, Reznikov S (1991) Comparison of transdermal to oral estradiol administration on hormonal and hepatic parameters in women with premature ovarian failure. J Clin Endocrinol Metab 73: 275–280

    Article  PubMed  CAS  Google Scholar 

  21. DeLignieres B, Baevant A (1986) Biological effects of estradiol-17beta in postmenopausal women: oral versus percutaneous administration. J Clin Endocrinol Metab 62: 1

    Article  Google Scholar 

  22. Derkx FHM, Stuenkel C, Schalekamp MPA, Visser W, Huisveld IH, Schalekamp MADH (1986) Immunoreactive renin, prorenin, and enzymatically active renin in plasma during pregnancy and in women taking oral contraceptives. J Clin Endocrinol Metab 63: 1008–1015

    Article  PubMed  CAS  Google Scholar 

  23. Hassager C, Riis BJ, Strom V, Guyene TT, Christiansen C (1987) The long-term effect of oral and percutaneous estradiol on plasma renin substrate and blood pressure. Circulation 76: 753–758

    Article  PubMed  CAS  Google Scholar 

  24. Sealey JE, Blumenfeld JD, Bell GM, Pecker MS, Sommers SC, Laragh JH (1988) On the renal basis for essential hypertension: nephron heterogeneity with discordant renin secretion and sodium excretion causing a hypertensive vasoconstriction-volume relationship. J Hypertension 6: 763–777

    Article  CAS  Google Scholar 

  25. Sealey JE, Itskovitz-Eldor J, Rubattu S, James GD, August P, Thaler I, Levron J, Laragh JH (1993) Estradiol and progesterone related increases in the renin- aldosterone system during ovarian stimulation and early pregnancy (submitted to J Clin Endocrinol Metab )

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Cacciabaudo, J.M., Sealey, J.E. (1994). Hormone Replacement Therapy and Hypertension: Relationship to the Renin-Angiotensin System. In: Safar, M.E., Stimpel, M., Zanchetti, A. (eds) Hypertension in Postmenopausal Women. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79077-5_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-79077-5_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-58144-4

  • Online ISBN: 978-3-642-79077-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics